Literature DB >> 8888700

Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy.

O Suhr1, A Danielsson, A Rydh, N Nyhlin, S O Hietala, L Steen.   

Abstract

Liver transplantation is the only effective treatment of familial amyloidotic polyneuropathy type I (FAP). The aim of the present investigation was to identify factors at the time of submission for transplantation that had impact on survival, with special reference to gastrointestinal disturbances. All 28 liver-transplanted FAP patients evaluated at Umeå University Hospital were included in the study. A modified body mass index was used to assess nutritional status. Intestinal examinations were performed to diagnose bile acid malabsorption, gastric retention, and bacterial contamination of the small bowel. A significantly improved survival rate was found for patients in a good nutritional state (P = 0.002). Peripheral neurological symptoms were unrelated to survival, whereas increased mortality was found for patients with bile acid malabsorption (P < 0.05). Bacterial contamination and gastric retention were common complications of the disease. In conclusion, malabsorption and malnutrition have a profound impact on the outcome of liver transplantation for familial amyloidotic polyneuropathy.

Entities:  

Mesh:

Year:  1996        PMID: 8888700     DOI: 10.1007/bf02093589

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden.

Authors:  R Andersson
Journal:  Acta Med Scand Suppl       Date:  1976

2.  A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves.

Authors:  C ANDRADE
Journal:  Brain       Date:  1952-09       Impact factor: 13.501

3.  Diagnosis of familial amyloidotic polyneuropathy in Sweden by RFLP analysis.

Authors:  G Holmgren; E Holmberg; A Lindström; E Lindström; I Nordenson; O Sandgren; L Steen; B Svensson; E Lundgren; A von Gabain
Journal:  Clin Genet       Date:  1988-03       Impact factor: 4.438

4.  Bacterial contamination of the small bowel evaluated by breath tests, 75Se-labelled homocholic-tauro acid, and scanning electron microscopy.

Authors:  O Suhr; A Danielsson; P Hörstedt; R Stenling
Journal:  Scand J Gastroenterol       Date:  1990-08       Impact factor: 2.423

5.  Electrophysiologic evaluation of the cardiac conduction system and its autonomic regulation in familial amyloid polyneuropathy.

Authors:  B L Bergfeldt; B O Olofsson; K O Edhag
Journal:  Am J Cardiol       Date:  1985-10-01       Impact factor: 2.778

6.  Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis.

Authors:  U Drugge; R Andersson; F Chizari; M Danielsson; G Holmgren; O Sandgren; A Sousa
Journal:  J Med Genet       Date:  1993-05       Impact factor: 6.318

7.  Familial amyloidosis with polyneuropathy. A long-term follow-up of 21 patients with special reference to gastrointestinal symptoms.

Authors:  L Steen; B Ek
Journal:  Acta Med Scand       Date:  1983

8.  Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of gastrointestinal disturbances in familial amyloidosis with polyneuropathy.

Authors:  O Suhr; A Danielsson; L Steen
Journal:  Scand J Gastroenterol       Date:  1992       Impact factor: 2.423

9.  Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells.

Authors:  M el-Salhy; O Suhr; R Stenling; E Wilander; L Grimelius
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

10.  Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate.

Authors:  G Holmgren; P M Costa; C Andersson; K Asplund; L Steen; L Beckman; P O Nylander; A Teixeira; M J Saraiva; P P Costa
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

View more
  10 in total

Review 1.  Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).

Authors:  Yukio Ando
Journal:  Med Mol Morphol       Date:  2005-09       Impact factor: 2.309

Review 2.  Systemic amyloidosis and the gastrointestinal tract.

Authors:  Prayman T Sattianayagam; Philip N Hawkins; Julian D Gillmore
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09-01       Impact factor: 46.802

3.  Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy.

Authors:  J Wixner; P Karling; A Rydh; R Hörnsten; U Wiklund; I Anan; O B Suhr
Journal:  Neurogastroenterol Motil       Date:  2012-08-16       Impact factor: 3.598

Review 4.  Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.

Authors:  Shukuro Araki; Yukio Ando
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

5.  Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis.

Authors:  Jonas Wixner; Torbjörn Sundström; Pontus Karling; Intissar Anan; Ole B Suhr
Journal:  BMC Gastroenterol       Date:  2015-04-25       Impact factor: 3.067

6.  THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease.

Authors:  Jonas Wixner; Rajiv Mundayat; Onur N Karayal; Intissar Anan; Pontus Karling; Ole B Suhr
Journal:  Orphanet J Rare Dis       Date:  2014-04-27       Impact factor: 4.123

Review 7.  Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis.

Authors:  Laura Obici; Ole B Suhr
Journal:  Clin Auton Res       Date:  2019-08-26       Impact factor: 4.435

8.  Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis.

Authors:  Alejandra González-Duarte; John L Berk; Dianna Quan; Michelle L Mauermann; Hartmut H Schmidt; Michael Polydefkis; Márcia Waddington-Cruz; Mitsuharu Ueda; Isabel M Conceição; Arnt V Kristen; Teresa Coelho; Cécile A Cauquil; Céline Tard; Madeline Merkel; Emre Aldinc; Jihong Chen; Marianne T Sweetser; Jing Jing Wang; David Adams
Journal:  J Neurol       Date:  2019-11-14       Impact factor: 4.849

9.  Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis.

Authors:  Jonas Wixner; Konen Obayashi; Yukio Ando; Pontus Karling; Intissar Anan
Journal:  Amyloid       Date:  2013-05-03       Impact factor: 7.141

10.  Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations.

Authors:  Radislav Nakov; Stayko Sarafov; Ventsislav Nakov; Mariana Gospodinova; Gianluca Ianiro; Tihomir Todorov; Albena Todorova; Ivailo Tournev
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.